Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: Summary statement of a first National Institutes of Health/Office of Rare Diseases Conference

被引：57

作者：

Gunay-Aygun, Meral

Avner, Ellis D.

Bacallao, Robert L.

Choyke, Peter L.

Flynn, Joseph T.

Germino, Gregory G.

Guay-Woodford, Lisa

Harris, Peter

Heller, Theo

Ingelfinger, Julie

Kaskel, Frederick

Kleta, Robert

LaRusso, Nicholas F.

Mohan, Parvathi

Pazour, Gregory J.

Shneider, Benjamin L.

Torres, Vicente E.

Wilson, Patricia

Zak, Colleen

Zhou, Jing

Gahl, William A.

机构：

[1] NHGRI, NIH, Mol Imaging Program, NIDDK, Bethesda, MD 20892 USA

[2] Med Coll Wisconsin, Childrens Hosp Wisconsin, Milwaukee, WI 53226 USA

[3] Indiana Univ, Sch Med, Bloomington, IN 47405 USA

[4] Albert Einstein Coll Med, Childrens Hosp Montefiore, New York, NY USA

[5] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA

[6] Univ Alabama, Tuscaloosa, AL 35487 USA

[7] Mayo Clin, Rochester, MN USA

[8] Harvard Univ, Massachusetts Gen Hosp, Massachusetts Gen Hosp Children, Sch Med, Cambridge, MA 02138 USA

[9] Harvard Univ, Inst Med, Autosomal Recess Polycyst Kidney Dis Congenital H, Boston, MA 02115 USA

[10] Harvard Univ, Inst Med, Dept Internal Med, Boston, MA 02115 USA

[11] George Washington Univ, Childrens Natl Med Ctr, Washington, DC USA

[12] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA

来源：

JOURNAL OF PEDIATRICS | 2006年 / 149卷 / 02期

关键词：

D O I：

10.1016/j.jpeds.2006.03.014

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

[No abstract available]

引用

页码：159 / 164

页数：6

共 35 条

[1] Calcium signaling and polycystin-2 [J].

Anyatonwu, GI ;

Ehrlich, BE .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (04) :1364-1373

[2] Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD) [J].

Bergmann, C ;

Senderek, J ;

Windelen, E ;

Küpper, F ;

Middeldorf, I ;

Schneider, F ;

Dornia, C ;

Rudnik-Schöneborn, S ;

Konrad, M ;

Schmitt, CP ;

Seeman, T ;

Neuhaus, TJ ;

Vester, U ;

Kirfel, J ;

Büttner, R ;

Zerres, K .

KIDNEY INTERNATIONAL, 2005, 67 (03) :829-848

[3] Autosomal recessive polycystic kidney disease: outcomes from a single-center experience [J].

Capisonda, R ;

Phan, V ;

Traubuci, J ;

Daneman, A ;

Balfe, JW ;

Guay-Woodford, LM .

PEDIATRIC NEPHROLOGY, 2003, 18 (02) :119-126

[4] Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease [J].

Consugar, MB ;

Anderson, SA ;

Rossetti, S ;

Pankratz, S ;

Ward, CJ ;

Torra, R ;

Coto, E ;

El-Youssef, M ;

Kantarci, S ;

Utsch, B ;

Hildebrandt, F ;

Sweeney, WE ;

Avner, ED ;

Torres, VE ;

Cunningham, JM ;

Harris, PC .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) :77-87

[5] Can progression of autosomal dominant or autosomal recessive polycystic kidney disease be prevented? [J].

Davis, ID ;

Dell, KM ;

Sweeney, WE ;

Avner, ED .

SEMINARS IN NEPHROLOGY, 2001, 21 (05) :430-440

[6] EGF-related growth factors in the pathogenesis of murine ARPKD [J].

Dell, KMR ;

Nemo, R ;

Sweeney, WE ;

Avner, ED .

KIDNEY INTERNATIONAL, 2004, 65 (06) :2018-2029

[7] Polycystins: polymodal receptor/ion-channel cellular sensors [J].

Delmas, P .

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2005, 451 (01) :264-276

[8]

Desmet VJ, 1998, MAYO CLIN PROC, V73, P80

[9] Diagnosis of cirrhosis by transient elastography (FibroScan):: a prospective study [J].

Foucher, J ;

Chanteloup, E ;

Vergniol, J ;

Castéra, L ;

Le Bail, B ;

Adhoute, X ;

Bertet, J ;

Couzigou, P ;

de Lédinghen, V .

GUT, 2006, 55 (03) :403-408

[10] Emerging therapies for polycystic kidney disease [J].

Gattone, VH .

CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (05) :535-542

← 1 2 3 4 →